1. News
  2. Sector

  3. Pharma & Healthcare

Covidien to buy Somanetics

India Infoline News Service | Mumbai | June 16, 2010 17:06 IST

The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.

Covidien Plc plans to buy Somanetics Corp. for US$25 a share in cash, according to reports. The deal valued at US$250mn. Covidien said the acquisition would broaden its medical equipment product offerings and create earnings growth over time. The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.







 

 
 
 
Recent Reports
News